IRISanRaf

CATURANO, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.086
NA - Nord America 2.129
SA - Sud America 1.262
EU - Europa 593
Continente sconosciuto - Info sul continente non disponibili 154
AF - Africa 73
OC - Oceania 15
Totale 8.312
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 2.632
US - Stati Uniti d'America 2.025
BR - Brasile 955
VN - Vietnam 539
IT - Italia 362
CN - Cina 290
BD - Bangladesh 286
AR - Argentina 126
HK - Hong Kong 109
EC - Ecuador 65
ID - Indonesia 60
NL - Olanda 53
MX - Messico 45
PK - Pakistan 43
CA - Canada 39
CO - Colombia 37
DE - Germania 31
GB - Regno Unito 30
IN - India 28
ZA - Sudafrica 28
PY - Paraguay 24
RU - Federazione Russa 21
CL - Cile 20
FR - Francia 15
IQ - Iraq 15
PL - Polonia 14
UA - Ucraina 13
IL - Israele 12
PE - Perù 12
VE - Venezuela 11
MA - Marocco 10
AU - Australia 9
IE - Irlanda 9
TR - Turchia 9
SA - Arabia Saudita 8
AT - Austria 7
EG - Egitto 7
TN - Tunisia 7
NZ - Nuova Zelanda 6
UY - Uruguay 6
UZ - Uzbekistan 6
AM - Armenia 5
BO - Bolivia 5
NP - Nepal 5
AL - Albania 4
CR - Costa Rica 4
ES - Italia 4
JO - Giordania 4
JP - Giappone 4
KZ - Kazakistan 4
MY - Malesia 4
TW - Taiwan 4
AO - Angola 3
AZ - Azerbaigian 3
KR - Corea 3
NI - Nicaragua 3
PT - Portogallo 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
EE - Estonia 2
FI - Finlandia 2
KE - Kenya 2
MD - Moldavia 2
MU - Mauritius 2
PH - Filippine 2
PR - Porto Rico 2
QA - Qatar 2
SE - Svezia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
BJ - Benin 1
BN - Brunei Darussalam 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
Totale 8.150
Salva come PNG Salva come JPEG
Città #
Dallas 952
San Jose 422
Ashburn 283
Singapore 225
Ho Chi Minh City 193
Rome 140
Hanoi 112
Beijing 111
Hong Kong 106
São Paulo 83
Amsterdam 44
New York 39
Los Angeles 32
Islamabad 30
Santa Clara 29
Chicago 28
Rio de Janeiro 27
Haiphong 25
Mexico City 25
Buffalo 24
Naples 22
Quito 22
Guayaquil 21
Biên Hòa 16
Brasília 16
Milan 16
Munich 16
Manaus 15
Thái Bình 15
Da Nang 14
Hải Dương 14
Bogotá 13
Guarulhos 13
Johannesburg 13
Curitiba 12
Can Tho 11
Netanya 11
Porto Alegre 11
Asunción 10
Belo Horizonte 10
Bắc Ninh 10
Campinas 10
Dhaka 10
Jakarta 10
Ninh Bình 10
Orem 10
Thái Nguyên 10
Boardman 9
Brooklyn 9
Buenos Aires 9
Duque de Caxias 9
Frankfurt am Main 9
Montreal 9
Salvador 9
Bắc Giang 8
Caxias do Sul 8
Council Bluffs 8
Florence 8
Fortaleza 8
Goiânia 8
Maricá 8
Quảng Ngãi 8
Recife 8
Santiago 8
Santo André 8
Warsaw 8
Bauru 7
Dublin 7
Joinville 7
Lima 7
Petrópolis 7
São José 7
Toronto 7
Bandung 6
Bari 6
Cabo Frio 6
Cape Town 6
Chennai 6
Ha Long 6
Hortolândia 6
Sorocaba 6
Sumaré 6
Suzano 6
Tashkent 6
Baghdad 5
Caruaru 5
Casablanca 5
City of London 5
Juiz de Fora 5
Lahore 5
Montevideo 5
Palermo 5
Ribeirão Preto 5
San Francisco 5
São Bernardo do Campo 5
Vila Velha 5
Amman 4
Aracaju 4
Auckland 4
Bagé 4
Totale 3.641
Salva come PNG Salva come JPEG
Nome #
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin 267
Advances in Nanomedicine for Precision Insulin Delivery 244
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 241
The impact of incidental hepatocellular carcinoma in liver transplantation: A growing concern 234
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 234
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 233
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 231
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 230
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 229
Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects? 221
Metabolic Dysfunction-Associated Steatotic Liver Disease in Klinefelter Syndrome: High Prevalence Uncovers an Unmet Need 219
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 213
SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review 196
Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition 174
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 164
Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 141
Bridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications 95
Risk Stratification For and Use of DOAC Therapies for Stroke Prevention in Patient with Atrial Fibrillation 91
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study 86
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 74
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 74
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 70
Sarcopenic obesity and weight loss-induced muscle mass loss 69
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 69
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial 67
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 67
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 67
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 66
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 66
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 59
Advancements in Cardiovascular and Antidiabetic Drug Therapy 58
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 56
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 56
Improvement of Global Longitudinal Strain and Myocardial Work in Type 2 Diabetes Patients on Sodium-Glucose Cotransporter 2 Inhibitors Therapy 53
Reply to Saeed et al. Comment on “Rinaldi et al. Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study. Viruses 2025, 17, 251” 53
Atrial fibrillation and stroke. A review on the use of vitamin K antagonists and novel oral anticoagulants 52
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 52
Antioxidant and Antidiabetic Potential of the Antarctic Lichen Gondwania regalis Ethanolic Extract: Metabolomic Profile and In Vitro and In Silico Evaluation 51
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 51
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 51
Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum 50
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 49
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 49
Insulin resistance and cancer: molecular links and clinical perspectives 49
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 48
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 48
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 48
Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study 48
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 47
Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects 46
Optimizing Body Composition During Weight Loss: The Role of Amino Acid Supplementation 46
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 46
Bivalirudin Use for Primary Percutaneous Coronary Intervention on Long-Term Mortality 46
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model 45
Right ventricular electrocardiographic abnormalities among hospitalized COVID-19 patients: Simple marker of worst clinical outcome 45
Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures 45
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 45
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 44
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 44
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 44
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry 44
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 43
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 43
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling 43
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 43
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 42
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 42
Rethinking the Diabetes–Cardiovascular Disease Continuum: Toward Integrated Care 42
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 42
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 42
HCC and molecular targeting therapies: Back to the future 42
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 42
Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 42
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 41
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 41
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 41
Clinical Utilization and Performance of Bempedoic Acid in an Italian Real-World Setting: Insight from Campania Region 40
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 40
Impact of sglt2 inhibitors on heart failure: From pathophysiology to clinical effects 40
Non-alcoholic fatty liver disease: From pathogenesis to clinical impact 39
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 39
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study 39
HAND GRIP STRENGTH EVALUATION IN RHEUMATOLOGIC DISEASES 39
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 39
Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets 38
Impact of Empagliflozin as add-on to Metformin vs Metformin continuation on MASLD Progression in Type 2 Diabetes: The IMAGIN Study 37
When the dual-chamber pacing system is the optimal choice for Brugada patients in need of implantable cardiac defibrillator 37
Post-fracture thromboprophylaxis: is it time for a change? 37
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 36
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 36
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 35
Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0 35
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 34
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 34
Comment on: Prevalence of micro and macro vascular complications and their risk factors in type 2 diabetes in saudi arabian population: An analysis from shis 34
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 33
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 33
New Advances in Cardiovascular Drugs: A Celebration of the 90th Birthday of Professor Akira Endo 32
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 32
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 32
Totale 7.501
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.331
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.593 0 0 0 0 0 0 4 18 2 227 1.264 1.078
2025/20265.663 192 361 1.381 1.267 239 306 378 292 348 315 289 295
2026/202756 56 0 0 0 0 0 0 0 0 0 0 0
Totale 8.312